Fingerprint
Dive into the research topics of 'Randomized Phase 2 Clinical Trial of Olaratumab in Combination with Gemcitabine and Docetaxel in Advanced Soft Tissue Sarcomas'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Randomized Phase 2 Clinical Trial of Olaratumab in Combination with Gemcitabine and Docetaxel in Advanced Soft Tissue Sarcomas
Steven Attia, Victor Villalobos, Nadia Hindi, Andrew J. Wagner, Bartosz Chmielowski, Gerard J. Oakley, Patrick M. Peterson, Matteo Ceccarelli, Robin L. Jones, Mark A. Dickson
Research output: Contribution to journal › Article › peer-review